Animal Health Market is Expected to grow at a CAGR of 10.5% during

Animal Health Market

𝑴𝒂𝒓𝒌𝒆𝒕 𝑶𝒖𝒕𝒍𝒐𝒐𝒌
• The global animal health market size was valued at USD 60.72 billion in 2023.
• The market is anticipated to reach USD 149.02 billion by 2032.
• The industry is projected to grow at a CAGR of 10.5% during the forecast period from 2024 to 2032.

𝑭𝒐𝒓 𝒎𝒐𝒓𝒆 𝒊𝒏𝒔𝒊𝒈𝒉𝒕𝒔 𝒊𝒏𝒕𝒐 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕, The following: https://www.polarismarketresearch.com/industry-analysis/animal-health-market/request-for-sample

𝑴𝒂𝒓𝒌𝒆𝒕 𝑶𝒗𝒆𝒓𝒗𝒊𝒆𝒘:

Animals are highly important to human life. They improve the welfare of humans in a number of ways, ranging from providing companionship and improving mental health. Besides, animals are used as models in biological research fields like drug testing and genetics. Animal health is a core element of food safety and security. It involves the use of tools such as antibiotics, treatments and vaccines to ensure the optimal health of animals and treat various medical conditions in them.

Animal health encompasses horses, lab animals, wildlife, aquatic animals, and other animal species in all settings. The products for animal health are available in various forms, including vaccines, parasiticides, analgesics, consumables, reagents and kits, and livestock monitoring software.

𝑴𝒂𝒋𝒐𝒓 𝑲𝒆𝒚 𝑷𝒍𝒂𝒚𝒆𝒓𝒔:
• Boehringer Ingelheim Gmbh
• Ceva Santé Animale
• Dechra Pharmaceuticals Plc
• Elanco
• Idexx Laboratories, Inc.
• Mars Inc.
• Merck & Co., Inc.
• Vetoquinol SA
• Virbac
• Zoetis

𝑭𝒓𝒐𝒎 𝑫𝒂𝒕𝒂 𝒕𝒐 𝑾𝒊𝒔𝒅𝒐𝒎: 𝑻𝒓𝒂𝒏𝒔𝒇𝒐𝒓𝒎 𝒀𝒐𝒖𝒓 𝑨𝒑𝒑𝒓𝒐𝒂𝒄𝒉 – 𝑩𝒖𝒚 𝒀𝒐𝒖𝒓 𝑪𝒐𝒎𝒑𝒍𝒆𝒕𝒆 𝑹𝒆𝒑𝒐𝒓𝒕 𝑻𝒐𝒅𝒂𝒚. https://www.polarismarketresearch.com/buy/3348/2

𝑮𝒓𝒐𝒘𝒕𝒉 𝑭𝒂𝒄𝒕𝒐𝒓𝒔 𝒂𝒏𝒅 𝑶𝒑𝒑𝒐𝒓𝒕𝒖𝒏𝒊𝒕𝒊𝒆𝒔

• The growing trend of adopting pets for companionship has resulted in increased exposure to diseases transmitted by animals across the globe. The upsurge in zoonotic diseases is anticipated to propel the market demand.

• An upsurge in the available treatment options for animal health further propels the industry’s growth. Furthermore, increased awareness about preventive measures is likely to have a favorable impact on the market expansion in the upcoming years.

𝑨𝒏𝒊𝒎𝒂𝒍 𝑯𝒆𝒂𝒍𝒕𝒉 𝑴𝒂𝒓𝒌𝒆𝒕 𝑹𝒆𝒑𝒐𝒓𝒕 𝑯𝒊𝒈𝒉𝒍 𝒊𝒈𝒉𝒕𝒔

• By 2023, the pharmaceutical segment held the largest share of the animal health market. Pharmaceuticals are widely used for the treatment of various conditions in animals, including infections, parasitic infestations, and chronic diseases. The continuous development of innovative drugs and therapies for different species contributes to the dominance of pharmaceuticals in the market.

• The veterinary hospitals & clinics segment is expected to witness the fastest CAGR during the forecast period. Access to state-of-the-art diagnostic equipment, specialized treatments, and surgical procedures attracts more pet owners to these facilities. Veterinary hospitals and clinics provide comprehensive healthcare services, including preventive care, diagnostics, surgery, and specialized treatments.

• In 2023, North America accounted for the largest market share due to the growing trend of pet humanization, which has led to increased spending on pet healthcare, developed veterinary infrastructure, and a significant livestock population.

• The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period due to increasing population and poultry farming to complete the milk and meat needs of Asian countries, which has led to an increase in the animal health market.

𝑪𝒍𝒊𝒄𝒌 𝒉𝒆𝒓𝒆 𝒕𝒐 𝑨𝒄𝒄𝒆𝒔𝒔 𝒕𝒉𝒆 𝑭𝒖𝒍𝒍 𝑹𝒆𝒑𝒐𝒓 𝒕: https://www.polarismarketresearch.com/industry-analysis/animal-health-market

Polaris Market Research has segmented the animal health market report based on animal type, product, distribution channel, end-Use, and region
Animal Health, Animal Type Outlook (Revenue – USD Billion, 2019 – 2032)

• Production Animals
o Goat
oh Sheep
o Cattle
o Poultry
• Companion animals
o Dogs
o Cat
o Horse
oOthers

Animal Health, Product Outlook (Revenue – USD Billion, 2019 – 2032)
• Biologics
o Vaccines
 Inactivated (Killed)
 Modified/Attenuated Live
 Other Vaccines
o Other Biologics

𝑬𝒙𝒑𝒍𝒐𝒓𝒆 𝑾𝒊𝒅𝒆-𝒓𝒂𝒏𝒈𝒊𝒏𝒈 𝑪𝒐𝒗𝒆𝒓𝒂𝒈𝒆 𝒐𝒇 𝑷 𝑴𝑹’𝒔 𝑯𝒆𝒂𝒍𝒕𝒉𝒄𝒂𝒓𝒆𝑳𝒂𝒏𝒅𝒔𝒄𝒂𝒑𝒆:

𝐂𝐡𝐫𝐨𝐧𝐢𝐜 𝐎𝐛𝐬𝐭𝐫𝐮𝐜𝐭𝐢𝐯𝐞 𝐏𝐮𝐥𝐦𝐨𝐧𝐚𝐫𝐲 𝐃𝐢 𝐬𝐞𝐚𝐬𝐞 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3456149/chronic-obstructive-pulmonary-disease-market-is-expected

The following: https://www.openpr.com/news/3458114/xerostomia-therapeutics-market-is-expected-to-reach-us-2-94

𝐂𝐚𝐫 𝐓 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3458611/car-t-cell-therapy-market-is-set-to-hit-us-118-680-68-million

The following: https://www.openpr.com/news/3458749/circulating-tumor-cells-market-to-receive-overwhelming-hike

𝐀𝐧𝐢𝐦𝐚𝐥 𝐕𝐚𝐜𝐜𝐢𝐧𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.openpr.com/news/3458803/animal-vaccines-market-is-expected-to-grow-to-us-31-07-billion
• Pharmaceuticals
o Anti-inflammatory
o Anti-infectives
o Parasiticides
o Analgesics
oOthers

• Diagnostics
o Consumables, reagents, and kits
o Instruments and devices
o Medicinal Feed Additives

• Equipment & Disposables
o Anesthesia Equipment
o Critical Care Consumables
o Patient Monitoring Equipment
o Rescue & Resuscitation Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Research Equipment

• Others
o Veterinary Telehealth
o Veterinary Software
o Livestock Monitoring

Animal Health, Distribution Channel Outlook (Revenue – USD Billion, 2019 – 2032)
• Retail
• E-commerce
• Hospital/Clinic Pharmacy

Animal Health, End Use Outlook (Revenue – USD Billion, 2019 – 2032)
• Point-of-care Testing/In-house Testing
• Veterinary Reference Laboratories
• Veterinary Hospitals & Clinics
• Others

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: [email protected]

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

This release was published on openPR.